text:
the happy birthday bob hope show
+ Bob Hope, KBE, KCSG, KSS, (born Leslie Townes Hope; May 29, 1903 – July 27, 2003), was an English-born American comedian, vaudevillian, actor, singer, dancer, author, and athlete who appeared on Broadway, in vaudeville, movies, television, and on the radio. He was noted for his numerous United Service Organizations (USO) shows entertaining American military personnel—he made 57 tours for the USO between 1941 and 1991. Throughout his long career, he was honored for this work. In 1997, the U.S. Congress declared him the "first and only honorary veteran of the U.S. armed forces." With a career spanning over 60 years, Hope appeared in over 70 films and shorts, including a series of "Road" movies co-starring Bing Crosby and Dorothy Lamour. In addition to hosting the Academy Awards fourteen times, he appeared in many stage productions and television roles, and was the author of fourteen books. He participated in the sports of golf and boxing, and owned a small stake in his hometown baseball team, the Cleveland Indians. He was married to performer Dolores Hope (née DeFina) for 69 years. Hope died at age 100.- WikiPedia
Please enjoy these 1 old time radio episodes:
Show 25 shows on page Show 50 shows on page Show 100 shows on page Show 200 shows on page Show 400 shows on page Show 800 shows on page Show All shows on page
05.29.1963 the happy birthday bob hope show
+ NBC-TV net, WNBC-TV, New York aircheck. Participating sponsors. A "special" dedicated to Bob Hope ...
Be the first to comment on "the happy birthday bob hope show "
I have a related image to this show
Only JPG, GIF and PNG file types are allowed
Add your comment about the show
Other "Comedy" Shows you may enjoy:
Will hay programme, the
Jack Webb Show
Eddie Bracken Show
Mother murphys boarding house
Sam pilgrims progress


text:
{Killion Group} My First by Melanie Shawn #Blogtour #bookspotlight
Sometimes authors become authors by accident. Other times, it's a planned adventure. I was at a crossroads in my life. I didn't know what to do with my energy, my writing, my passion. Luckily, I found an outlet-writing. Melanie Shawn is here to share her book My First and her thoughts on Crossroads.... Take it away Melanie!
Melanie Shawn's The Crossroads Series – What Makes Being At A Crossroads In Life Such a Compelling Theme?
The writing team of sisters Melanie and Shawna discuss why they chose the theme of "Big Life Choices" for their Crossroads Series.
Robert Frost, in his immortal poem, describes one of the biggest conundrums in life.
"Two roads diverged in a yellow wood,
And be one traveler, long I stood"
There is something so gut-wrenching about facing a metaphorical fork in the road. You can only go one way, and the what the rest of your life will look like is based on that one monumental decision.
Of course, people face these crossroads in life every day. They decide whether to enter or leave relationships, they decide what job to take and what job to pass on, they decide whether to move across the country or not. They decide whether the time is right to start a family.
It's not the rarity of the experience that makes the facing a crossroads so compelling, it's the struggle. We all do it. We go back and forth mentally, we try to see down the divergent paths to envision what our lives would be like under each of the two sets of circumstances we are choosing between, even though we know that's folly! There's no way for us to predict the outcome.
The truth is, the only way to make a big "crossroads" kind of decision is to follow your heart. You have to ignore the clenching in your gut, the uncertainty, the little voice in your head that says you aren't good enough, and just...leap. You have to take a giant leap of faith.
Decisions. Choices. Crossroads.
We knew immediately when the concept occurred to us that it simply had to be the theme of our second series of novels. There is such a great arc, and there is so much rich emotional material for mining, in a situation where one or both of the characters have to dig deep, determine what is right for them, and then take a huge leap of faith.
Of course, since we're romance writers, we know that leap will pay off for them. They will take that scary jump only to land in their lover's arms and find out that they were launching themselves right into their own HEA all along.
But the "good stuff" is in how they manage to get to the point where they feel ready to jump!
Melanie Shawn Bio
Melanie Shawn is the writing team of sister duo Melanie and Shawna. Originally from Northern California, they both migrated south and now call So Cal their home.
Growing up, Melanie constantly had her head in a book and was always working on short stories, manuscripts, plays and poetry. After graduating magna cum laude from Pepperdine University, she went on to teach grades 2nd through 8th for five years. She now spends her days writing and taking care of her furry baby, a Lhasa Apso named Hercules. In her free time, her favorite activity is to curl up on the couch with that stubborn, funny mutt and binge-watch cable TV shows on DVD (preferably of at least eight seasons in length - a girl's gotta have her standards!).
Shawna always loved romance in any form - movie, song or literary. If it was a love story with a happy ending, Shawna was all about it! She proudly acknowledges that she is a romanceaholic. Her days are jam-packed with writing, being a wife, mom aka referee of two teens, and indulging in her second passion (dance!) as a Zumba instructor. In the little free time she has, she joins Melanie in marathon-watching DVDs of their favorite TV programs.
They have joined forces to create a world where True Love and Happily Ever After always has a Sexy Twist!
Jason Sloan is known as Harper's Crossing's resident Romeo, and he's never had to work too hard to live up to that nickname. With his easygoing charm, whiskey-colored brown eyes, and sinfully sexy half smile, women just seem to fall all over themselves when he's around.
Well...most women, anyway. Katie Lawson's the one woman who isn't putty in his hands, and she's the only one he's ever wanted in his arms.
Katie Lawson left Harper's Crossing in the middle of the night ten years ago, immediately after her high school boyfriend Nick's funeral. She left behind all memories of Nick, and she left behind her life-long best friend, Jason Sloan.
Now she's on the fast track to junior partner at one of San Francisco's top law firms. She's made a life for herself that's all about maintaining order and sticking to the rules. Rule #1 is keeping herself WAY too busy to think about all that she ran away from. If she can do that, after all, she can keep everything under control.
But that rule is about to be broken. She's headed back home to be the maid of honor in Nick's little sister's wedding. It's time to face the truth she's been avoiding all these years, the same one that sent her running ten years ago - that maybe she didn't lose her first love the summer after high school. Maybe her first love has been waiting for her all this time, at home in Harper's Crossing.
My First Excerpt
Katie opened her mouth to speak, but nothing came out. She snapped it shut. She tried again. Same result. She imagined she looked like a trout on the banks of a river, flapping her mouth open and shut for no apparent reason.
The realization of how silly she must look gave her just the extra edge of courage she needed to jump off the cliff.
"Jason, I...I wanted to...I wanted to tell you that..." she steeled herself for what she knew her physical reaction would be as she forced herself to look up into those gorgeous brown eyes, which resembled nothing so much as pools of warm and melty milk chocolate...
The expression on Jason's face when she raised her eyes brought her up short. She narrowed her eyes.
"Why do you look so smug?" she asked suspiciously.
Rather than answering, he smirked and bent down, putting his mouth right next to her ear. His hot breath assailed her neck and she began to feel light-headed again.
Wait...was this....OH NO! Panic attack #2 might be on the horizon.
Not in front of Jason, PLEASE, not in front of Jason, Katie begged the Universe. It seemed like the Universe must have more important things on its mind, however because - oh, lord. Now the shallow breathing was starting.
Jason's breath on her neck, however, was anything but shallow. It was deep. And heavy. And warm. And full of desire. And...oh, man, that lightheadedness was just getting worse and worse.
Jason had her pinned up against the trunk of her car. Her mind was screaming at her to push him away and RUN as fast and as far as she could. Hey, it had worked in the past. Her body, however, was sending her some very different signals.
"I'm not smug, Kit Kat," Jason informed her, his deep voice rumbling in his chest.
"Wha...huh...?" Katie mumbled.
Jason laughed lightly, "I was just saying that I'm not smug. Just happy to know that I still get under your skin."
Katie didn't respond. She didn't even really hear what he said, she'd stopped trying to pay attention to the words. Stupid words. They just got in the way of listening to his voice...that silky, deep voice.
Jason traced his thumb down the back of Katie's neck slowly, sensuously, and then continued across her shoulder and down her arm. When he reached her waist, he slipped his hand around her easily, spreading his fingers slowly and firmly, grasping her back with a familiarity that felt as dangerous as it did comforting.
His thumb began to gently massage the small of her back, sending sharp zings of electricity ping-ponging off of her nerve endings. She wanted to stop those little zings of pleasure in their tracks. She wanted to ignore, suppress, deny...anything!
She needed to push him away and get some distance is what she needed to do. Her knees began to buckle. Any time now, a little voice in the back of her head whispered. Any time you want to get a jump on creating that distance would be perfect.
That was, however, not what Katie did. No matter how hard her lizard brain screamed at her to push him away...step away...jump away...DANCE away, even...all Katie found herself doing was looking up into his chocolate brown eyes as she melted into his embrace.
Katie heard a low moan escape from Jason's throat and was suddenly hyper-aware of how close their lips were to each other. A shiver ran through her as she contemplated the nearness of those delicious, sexy lips.
Katie's breathing became more labored, but not in an out-of-control, panic-attacky kind of way. No, it was more of a body-coming-alive-for-the-first-time-in-years kind of way.
She vaguely wondered what was going to happen next, but couldn't make herself focus too much on the future. Not when the present was this flipping interesting!
Her brain might be telling her to get out of this situation, to think about the consequences – but her body was perfectly content to ride this little scene out and see where it went thankyouverymuch.
Why did it seem that she was utterly incapable of listening to her brain in any situation where Jason Sloan was involved?
Amazon: http://bit.ly/myfirstamazon
B&N: http://bit.ly/myfirstbarnes
Website: http://melanieshawn.com/
Facebook: https://www.facebook.com/melanieshawnbooks
Twitter: https://twitter.com/MelanieShawn
Youtube: http://www.youtube.com/watch?v=mka92etUNsE

redpajama_set_name: RedPajamaCommonCrawl


LG has announced a new smartphone in Korea, the LG Q8. The LG Q8 is an entry-level smartphone, and it actually comes with a stylus, if that's something you're into. We don't really see many phones that ship with styluses, especially entry-level ones, but this one does, with a basic stylus. The LG Q8 also sports really thin bezels, and its display comes with rounded corners. The device features a single camera on the back, and a fingerprint scanner on the back as well, along with an LG logo.
On the right-hand side of the LG Q8, you'll notice a power / lock key, while its volume up and volume down buttons are included on the left. A 3.5mm headphone jack is a part of the package as well, and it's located on the bottom of the phone. The device features a 6.2-inch fullHD+ (2160 x 1080) FullVision display, along with 4GB of RAM and 64GB of expandable memory (expandable up to 2TB). The device is fueled by the Snapdragon 450 64-bit octa-core processor, and it includes a 3,300mAh battery as well, which supports Quick Charge 3.0 fast charging. A 16-megapixel camera can be found on the back of this phone, while a single 5-megapixel camera (100-degree Super Wide Angle lens) is included on the phone's front side. The LG Q8 comes with a Hi-Fi Quad DAC, and DTS:X 3D Surround sound. Android 8.1 Oreo comes pre-installed on this smartphone, with LG's custom UI, while the device also includes Bluetooth 4.2, and a Type-C USB port.
LG has introduced this smartphone in two color variants, Aurora Black and Moroccan Blue, while the device is priced at 539,000 won ($470). The LG Q8 is still not available for purchase in Korea, but it will be in the near future, said LG. It remains to be seen if LG plans to push this phone to more markets, but for the time being, it's exclusive to Korea.


text:
G3 Sportsman TV
FLW TV
Bassmaster Videos
Online Fishing TV
Florida Sport Fishing
Extreme Angler TV
Fishing & Boating News
Anglers Inn International Continues Complimentary Memberships to B.A.S.S.
by: Ron Giudice, Blue Heron Communications
(May 3, 2018 - COEUR D' ALENE, Idaho) Billy Chapman Jr., owner and founder of Anglers Inn International, believes everyone should become a B.A.S.S. member. And he puts his money where it supports his dedication to bass fishing. The Freshwater Fishing Hall of Famer and a member of the Bass Anglers Sportsman Society (B.A.S.S.) will buy an annual B.A.S.S. membership for every angler that fishes at Anglers Inn International Mexico lodges at Lakes El Salto or Picachos. Anglers get to enjoy the very best bass fishing lake on the planet and become members of the world's best fishing club.
Chapman's passion for hosting bass anglers is evident with his popular 5-star fishing destinations in Mexico and Brazil and new operations in Idaho. His dedication to the bass angler and to the members of B.A.S.S. is supported with this membership offer and his special discount packages exclusive to B.A.S.S. members.
"I cherish my B.A.S.S. membership and want all of my customers to enjoy being a part of such a fine organization," said Chapman. "I don't think we'd have the quality of bass fishing in the United States or Mexico if we did not have B.A.S.S. I'm continuing our program to pay the B.A.S.S. membership fee for every angler fishing at either of our Mexico lodges through April 2019."
For those anglers already a B.A.S.S. member their membership will be extended one year. There is no obligation by the angler other than staying at an Anglers Inn lodge. One benefit of being a member is receipt of the critically acclaimed and highly popular Bassmaster Magazine.
The exclusive discount offer to B.A.S.S. members also continues. Members booking a reservation to either Mexico location will receive up to a $400 discount on the trip if taken between September 19 and November 4, 2018.
Chapman has been a leader in the outfitter industry for over 43 years and an inductee in the National Freshwater Fishing Hall of Fame, the only outfitter to be so honored. Chapman's offerings in Mexico and Brazil are legendary for exceptional fishing and the highest caliber of service and facilities.
B.A.S.S. operates the most prestigious and competitive fishing tournament program in the world, publishes Bassmaster and B.A.S.S. Times magazines, has the industry-leading website, Bassmaster.com, manages the B.A.S.S. Nation network of state and local chapter affiliates and has a far-reaching conservation focus. Celebrating its 50th anniversary, the organization was founded in 1968 by Ray Scott.
To learn more about Anglers Inn International fishing opportunities login to www.anglersinn.tv and www.anglersinn.com or call 1-800-GOTAFISH (1-800-468-2347). For more information on B.A.S.S., go to www.bassmaster.com.
FishingWorld.com
Phone:903-882-8877 or 903-882-8878 — Fax: 972-619-8776
Copyright © FishingWorld.com. All rights reserved. By accessing this web site, you agree to the terms of use.


ABSTRACT. Expected accession of the Czech Republic into the European Union gives a new stimulus to activities that are leading to the incorporation of firms, particularly to mergers and acquisitions (M&A). Liberalization of energy, transport, telecommunication and postal services will clearly accelerate many transactions related to privatisation, which cause enhanced activity in the field of M&A.
The aim of the paper is to analyse the fundamental economic and legal aspects of the development of the Czech economy over the last decade motivating foreign companies to invest in the Czech Republic. It deals with the reason for decreased rating of the Czech Republic caused by low level of legal rules in business. The paper appraises the qualitative changes in the system of the Czech legal regulation of mergers and acquisitions and. the level of approximation of the European law. It identifies the legal instruments strengthening the foreign investors.
KEYWORDS: Czech Republic, laws in business, mergers and acquisitions, foreign direct investment.


Объем перевалки грузов в порту Гамбурга в первом квартале составил 35,6 млн. т, что означает достаточную стабильность в работе. Такие показатели грузопереработки достигнуты за счет роста объемов зерновых грузов и угля, а объемы контейнерообработки и неконтейнеризованных сухих грузов падают. В частности, объем обработки контейнеров упал за период первого квартала на 2, 3%, поскольку уменьшился поток контейнеризованных грузов из России и в нее из-за экономических санкций, которые были введены между Россией и западными странами, а также по причине падения курса рубля. В тот же период времени грузообработка в портах Антверпена и Роттердама возросла, а в порту Бремен/Бременхафен продолжает уменьшаться.
Cargo throughput at the port of Hamburg remained unchanged in the first quarter at 35.6 million tonnes (+0.1% year on year) as gains in dry bulk liftings were offset by a drop in containers.
Bulk traffic was up 12.3% to 11.7 million tonnes in the first three months driven by higher grain and coal volumes while containerised and non-containerised general cargo suffered a -4.9% fall to 23.9 million tonnes, according to port marketing agency Hafen Hamburg.
The number of containers handled across the Hansestadt's four terminals dropped by 2.3% to 2,3 million teu, chiefly due to losses in transhipment volumes to and from Russia following the introduction of trade sanctions between Russia and western countries and the depreciation of the ruble. Gateway intermodal cargo, which leaves and arrives at the port by road, rail, and barge, showed an encouraging trend, rising by 7.3% to 1.5 million teu.
Germany's second-largest port Bremen/Bremerhaven has not yet released its first quarter results, but statistics for the first two revealed losses in all relevant types of cargo: vehicles down by 6.3% year on year, containers down 1.6%. By contrast, cargo handling in both Rotterdam and Antwerp increased by 7.2% and 5.9%, respectively, in the first quarter.


text:
Sarepta Therapeutics Announcement: Positive Preliminary Results from the First Three Children Dosed in the Phase 1/2a Gene Therapy Micro-dystrophin Trial
-- Biopsies performed at Day 90 showed robust micro-dystrophin expression in muscle measured by all methods and observed in all three patients --
-- Significant decrease in levels of serum creatine kinase (CK), an enzyme biomarker strongly associated with muscle damage caused by Duchenne muscular dystrophy --
-- No serious adverse events (SAEs) observed --
CAMBRIDGE, Mass., June 19, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases, announced that at the Company's R&D Day, Jerry Mendell, M.D. of Nationwide Children's Hospital presented positive preliminary results from its Phase 1/2a gene therapy clinical trial assessing AAVrh74.MHCK7.micro-Dystrophin in individuals with Duchenne muscular dystrophy (DMD). Dr. Mendell presented the following preliminary data on the first three patients enrolled in the study:
All patients showed robust expression of transduced micro-dystrophin, which is properly localized to the muscle sarcolemma, as measured by immunohistochemistry. Mean gene expression, as measured by percentage of micro-dystrophin positive fibers was 76.2% and the mean intensity of the fibers was 74.5% compared to normal control.
All post-treatment biopsies showed robust levels of micro-dystrophin as measured by Western blot, with a mean of 38.2% compared to normal utilizing Sarepta's method, or 53.7% compared to normal pursuant to Nationwide Children's quantification of Sarepta's method that adjusts for fat and fibrotic tissue.
A mean of 1.6 vector copies per cell nucleus was measured in patients, consistent with the high micro-dystrophin expression levels observed.
All patients showed significant decreases of serum creatine kinase (CK) levels, with a mean reduction of CK of over 87% at Day 60. CK is an enzyme associated with muscle damage and patients with DMD uniformly exhibit high levels of CK. Indeed, significantly elevated CK is often used as a preliminary diagnosis tool for DMD, which is then followed by confirmatory genetic testing.
No serious adverse events (SAEs) were observed in the study. Two patients had elevated gamma-glutamyl transferase (GGT) that resolved with increased steroids within a week and returned to baseline levels. There were no other significant laboratory findings. Patients had transient nausea generally during the first week of therapy coincident with increased steroid dosing.
Dr. Mendell, the study's principal investigator, in collaboration with Louise Rodino-Klapac, Ph.D., empirically optimized the AAVrh74.MHCK7 specifically for DMD:
The AAVrh74 vector can be systemically and robustly delivered to skeletal, diaphragm and cardiac muscle without promiscuously crossing the blood brain barrier, making it an ideal candidate to treat neuromuscular diseases.
As a rhesus monkey-derived AAV vector, AAVrh74 appears to show lower immunogenicity rates in existing early-stage clinical studies than expected with other human AAV vectors.
The MHCK7 promoter has been chosen for its ability to robustly express in the heart, which is critically important for patients with DMD, who typically die from pulmonary or cardiac complications. In preclinical models, micro-dystrophin expression in the heart was observed to be up to 120% of the micro-dystrophin levels observed in skeletal muscles.
The transgene was designed to maintain spectrin-like repeats 2 and 3, which has been reported to be important for maintaining the protective functional characteristics of dystrophin.
"As a genetic medicine company, our goal is to work with the world's leading clinicians and scientists to advance scientific discoveries to the clinic and, ultimately, to therapies that profoundly improve and extend the lives of those living with Duchenne muscular dystrophy and other rare, fatal diseases," stated Doug Ingram, Sarepta's president and chief executive officer. "Since the discovery of the dystrophin gene in 1986, scientists, clinicians, patient advocates and the biotech ecosystem have tirelessly searched for ways to restore or replace dystrophin and rescue boys with DMD from the damage and early death. Dr. Mendell's results, if confirmed in additional patients, studies, measures and time points, represent a monumental leap forward in the direction of our goal."
Dr. Mendell added, "I have been waiting my entire 49-year career to find a therapy that dramatically reduces CK levels and creates significant levels of dystrophin. Although the data are early and preliminary, these results, if they persist and are confirmed in additional patients, will represent an unprecedented advancement in the treatment of DMD. I look forward to treating more patients in the clinical study to generate the data necessary to bring this therapy to patients with DMD, with the goal of dramatically changing the course of the disease."
"For years, PPMD has been interested in the potential of gene therapy as a treatment for Duchenne. At a critical moment in development in early 2017 – with the help and support of our amazing community – we were thrilled to be able to fund this important project of Drs. Mendell and Rodino-Klapac. To have reached this moment today is incredible and we are grateful to Sarepta for their investment and partnership in moving this therapeutic approach forward. While these are early days and work remains to fully understand the full potential of gene therapies, these first signals are encouraging. We remain hopeful that this will lead to a viable treatment for Duchenne," stated Pat Furlong, Parent Project Muscular Dystrophy's (PPMD) founding president and chief executive officer.
PPMD committed $2.2 million to the trial, with support from additional Duchenne foundations and families.
About Sarepta Therapeutics
Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases. The Company is primarily focused on rapidly advancing the development of its potentially disease-modifying Duchenne muscular dystrophy (DMD) drug candidates. For more information, please visit www.sarepta.com.
This press release contains "forward-looking statements." Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," "intends," "potential," "possible" and similar expressions are intended to identify forward-looking statements. These forward-looking statements include statements regarding the design and potential benefits of the AAVrh74 vector, including its ability to systemically and robustly being delivered to skeletal, diaphragm and cardiac muscle without promiscuously crossing the blood brain barrier and its potential to show lower immunogenicity rates; the ability of the MHCK7 promoter to robustly express in the heart; the potential of the transgene to maintain the protective functional characteristics of dystrophin; Sarepta's goal to work with the world's leading clinicians and scientists to advance scientific discoveries to the clinic and, ultimately, to therapies that profoundly improve and extend the lives of those living with DMD and other rare, fatal diseases; and the potential of Dr. Mendell's results to represent a monumental leap forward in the direction of Sarepta's goal, an unprecedented advancement in the treatment of DMD and dramatically change the course of the disease.
These forward-looking statements involve risks and uncertainties, many of which are beyond Sarepta's control. Actual results could materially differ from those stated or implied by these forward-looking statements as a result of such risks and uncertainties. Known risk factors include, among others: success in preclinical testing and early clinical trials, especially if based on a small patient sample, does not ensure that later clinical trials will be successful, and initial results from a clinical trial do not necessarily predict final results; Sarepta's ongoing research and development efforts may not result in any viable treatments suitable for commercialization due to a variety of reasons, some of which may be outside of Sarepta's control, including the results of future research may not be consistent with past positive results or may fail to meet regulatory approval requirements for the safety and efficacy of product candidates, possible limitations of Company financial and other resources, manufacturing limitations that may not be anticipated or resolved for in a timely manner, and regulatory, court or agency decisions, such as decisions by the United States Patent and Trademark Office with respect to patents that cover Sarepta's product candidates; and even if Sarepta's programs result in new commercialized products, Sarepta may not achieve any significant revenues from the sale of such products; and those risks identified under the heading "Risk Factors" in Sarepta's most recent Annual Report on Form 10-K for the year ended December 31, 2017 and most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (SEC) as well as other SEC filings made by the Company which you are encouraged to review.
Any of the foregoing risks could materially and adversely affect the Company's business, results of operations and the trading price of Sarepta's common stock. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. Sarepta does not undertake any obligation to publicly update its forward-looking statements based on events or circumstances after the date hereof.
Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.
Source: Sarepta Therapeutics, Inc.
Media and Investors:
Sarepta Therapeutics, Inc.
Ian Estepan, 617-274-4052
W2O Group
Rachel Hutman, 301-801-5540


Metal wall art has ageless appeal. You can never go wrong fashionably, if you make use of one to enhance the splendor of your home.
Give your room the historical air and enigmatic feel by introducing some exquisite metal wall art in it. The wall arts speak volumes about the beauty of life, etched with accuracy and true sense of beauty. Each art piece, whether a simple frame or sculpture, is finely handcrafted to enhance the aesthetic standards of your home.
For ages, colorful and abstract paintings, which have adorned the walls has best represented wall art. Now, however, metal work is in demand; such pieces truly exude style and art. However, the metal wall art involves an assortment of metal working techniques, such as casting, brazing, welding and hand shaping. The final touch is applied with various finishing details. At the end, a protective coating is applied, in order to give the outer chic look.
A metal wall art is usually a three dimensional framework, wherein the sculptures are embossed and therefore look very real. The sculpture designs involve waterfall weaving, textured aluminum, wavy weaving and Thunderbirds. The metal art works are handcrafted and assembled by in-house artisans or by the apprentice sculptors under the leadership of a Studio Master Craftsman.
The handwork is expertly sculptured from metals, such as copper, brass and steel; the piece is exquisitely designed to give the classic look. Wall art is not only meant for the indoor décor and styling; it can be used to embellish the outdoors. The mix of classic and sophisticated look of the metal work gives a new meaning to the homely ambiance.
To achieve the best work, hire the best sculptor in town. The metal work designs should be original in style and very much in accord with your taste and preference. The most interesting thing about metal wall art is that they are timeless beauty and most of them are nature-inspired. It gives an impression that the sculpture has been excavated from a long-lost ruin. Surely, the metal work will always inspire wonder in the minds of the people.


Who is really under that mask?
Let Safecell Security protect you and your family this Halloween. We offer a wide range of Security Systems across the North West of England. We can offer you CCTV, Intruder Alarms, Access Control, Fire Alarms and Door Entry Security Systems.
Call us today on 0161 762 9936 and one of our team members will be more than happy to help.


text:
Q: Need help so its less characters in total So i ended up getting it down to 139 once all spaces are removed now i just need 8 more to beat my teacher any recomendations welcomed thanks also i moved it back into intellij just so its easier for me to change
package com.company;
public class Main {
public static void main(String[] a) {
    for(int i=1;i++<100;)System.out.println(i%15==0?"Code Dojo":i%5==0?"Dojo":i%3==0?"Code":""+i);}}

A: I'm down to this answer.
remove the public in main class
remove extra ""+
Total remove character 9
class X {public static void main(String[] a) {for(int i=1;i++<100;)System.out.println(i%15==0?"Code Dojo":i%5==0?"Dojo":i%3==0?"Code":i);}}

Well I think its not also part of the rules where we fully utilize the arguments
class X{public static void main(String[] x){for(int i=1;i++<100;)System.out.println(i%15==0?x[0]:i%5==0?x[1]:i%3==0?x[2]:i);}}

And run the code like this:
java X "Code Dojo" "Dojo" "Code"

Here you go my best answer.

A: You can use interface to get rid of public, but honestly you should check out the code golf StackExchange. Not going to space out the code except for those required to compile, because spaces are ugly in golfing.
interface M{static void main(String[]a){for(int i=0;++i<100;)System.out.println(i%3!=0?i%5!=0?i:"Dojo":i%5==0?"Code Dojo":"Code");}}

Do beware that the quotation marks in the code won't compile because I typed this out on my phone, so you'll have to replace them.

redpajama_set_name: RedPajamaStackExchange